Related Experiment Video
Updated: May 27, 2026

Fractionation for Resolution of Soluble and Insoluble Huntingtin Species
Published on: February 27, 2018
α-Synuclein modifies huntingtin aggregation in living cells
Federico Herrera1, Tiago Fleming Outeiro
1Cell and Molecular Neuroscience Unit, Instituto de Medicina Molecular, Lisboa, Portugal.
Huntingtin (Htt) and alpha-synuclein (α-syn) co-aggregate, impacting protein aggregation in neurodegenerative diseases like Huntington's disease and Parkinson's disease.
Area of Science:
- Neurobiology
- Molecular Biology
- Biochemistry
Background:
- Neurodegenerative diseases, including Huntington's disease (HD) and Parkinson's disease (PD), are linked to protein aggregation in the central nervous system.
- These protein aggregates often comprise multiple aggregation-prone proteins, suggesting complex interactions contribute to disease pathology.
Purpose of the Study:
- To investigate the initial co-aggregation steps between huntingtin (Htt) and alpha-synuclein (α-syn).
- To understand how these proteins interact and influence each other's aggregation behavior.
Main Methods:
- Utilized a bimolecular fluorescence complementation (BiFC) assay.
- Studied the co-aggregation of Htt (exon 1) and α-syn in a cellular context.
Main Results:
- Demonstrated that Htt (exon 1) oligomerizes with α-syn and sequesters it in the cytosol.
- Observed that α-syn influences Htt aggregation by increasing the number of cells with aggregates, reducing aggregate count per cell, and enlarging aggregate size.
Conclusions:
- Co-aggregation of aggregation-prone proteins like Htt and α-syn is a significant factor in the histopathology of neurodegenerative disorders.
- These protein interactions may represent a common mechanism underlying various neurodegenerative conditions.
More Related Videos
09:16Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation
Published on: June 26, 2018
11:22Generation of Native, Untagged Huntingtin Exon1 Monomer and Fibrils Using a SUMO Fusion Strategy
Published on: June 27, 2018